| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $66.8M | +39.2% |
| R&D Expense | $38.5M | -60.2% |
| SG&A Expense | $21.2M | -10.7% |
| Operating Income | $6.3M | +108.6% |
| Pre-tax Income | $8.8M | +112.9% |
| Income Tax | $261K | — |
| Net Income | $8.6M | +112.5% |
| EPS (Basic) | $0.15 | +111.8% |
| EPS (Diluted) | $0.15 | +111.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $40.3M | -23.9% |
| Current Assets | $67.3M | -37.3% |
| Total Assets | $68.9M | -37.7% |
| Current Liabilities | $8.9M | -81.9% |
| Total Liabilities | $9.9M | -84.6% |
| Stockholders' Equity | $59.0M | +28.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.6M | +46.2% |